Drawing for N NEULAND

USPTO serial 98508238

N NEULAND

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
STEINPFAD, SARAH E
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with N NEULAND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marina F. Cunningham

Marina F. Cunningham McCormick, Paulding & Huber PLLC185 Asylum StreetCityPlace II, Fl. 18Hartford, CT 06103

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry.ACTIVE—
005Pharmaceutical products for treating cardiovascular diseases, respiratory diseases and neurological disorders; dietetic substances adapted for medical use in the nature of dietic food supplements, dietic infusions for medical purposes, dietetic foods formulated for medical use, and dietetic preparations adapted for medical purposes.ACTIVE—
009Scientific, optical, lifesaving apparatus and instruments, namely, spectrometers, spectrophotometers for measuring relative DNA, RNA, and protein, laboratory chemical reactors, refractometer, chromatography apparatus for use in protein purification, chromatography apparatus for laboratory use, electron microscopes, polarimeters; automated peptide synthesizers and purification systems and safety systems for active pharmaceutical ingredients and peptides, all of the foregoing comprised primarily of imaging apparatus and instruments for use in the study of proteins and peptides in drug development; laboratory life saving systems comprised primarily of laboratory equipment in the nature of fume hoods, ventilated cabinets, and containment enclosures in the nature of laboratory equipment, namely, ductless fume enclosures and forensic drying cabinets; and Data processing equipmentACTIVE—
042Scientific and technological services, namely, research and design relating thereto in the field of pharmaceutical development, synthesis of active pharmaceutical ingredients, peptide development, and process optimization; Industrial analysis and research services in the nature of scientific services, namely, active pharmaceutical ingredients research and analysis services, analytical testing and method development for complex active pharmaceutical ingredients and peptide development research and services, and industrial research in the field of pharmaceutical product development and custom synthesis of complex active pharmaceutical ingredients.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 21, 2026EX1GSOU EXTENSION 1 GRANTED—
Oct 21, 2026EXT1SOU EXTENSION 1 FILED—
Oct 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 21, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 24, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 24, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2026DOCKASSIGNED TO EXAMINER—
Dec 2, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 2, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jan 27, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 27, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 27, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 26, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 26, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 26, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2024DOCKASSIGNED TO EXAMINER—
Oct 6, 2024MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 6, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 18, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance